Sean Bohen
2022
In 2022, Sean Bohen earned a total compensation of $6M as President and Chief Executive Officer at Olema Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $372,600 |
|---|---|
| Option Awards | $3,923,168 |
| Salary | $615,800 |
| Stock Awards | $1,064,700 |
| Other | $13,370 |
| Total | $5,989,638 |
Bohen received $3.9M in option awards, accounting for 65% of the total pay in 2022.
Bohen also received $372.6K in non-equity incentive plan, $615.8K in salary, $1.1M in stock awards and $13.4K in other compensation.
Rankings
In 2022, Sean Bohen's compensation ranked 513th out of 5,760 executives tracked by ExecPay. In other words, Bohen earned more than 91.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 513 out of 5,760 | 91st |
Division Manufacturing | 214 out of 3,136 | 93rd |
Major group Chemicals And Allied Products | 64 out of 1,422 | 96th |
Industry group Drugs | 52 out of 1,323 | 96th |
Industry Pharmaceutical Preparations | 38 out of 969 | 96th |
Source: SEC filing on April 26, 2024.
Bohen's colleagues
We found two more compensation records of executives who worked with Sean Bohen at Olema Pharmaceuticals in 2022.